A straightforward formula, V = H i ·b 2 − 1 · V i , which minimizes the product of transfusion time and volume has been derived. V i represents the initial volume of the packed red blood cells (PRBCs) whereas H i represents their initial hematocrit. The coefficient b is based upon an approximate exponential representation of viscosity as a function of added volume V and H i . This formula allows for the minimization of both the volume of diluent, added to a known volume of PRBCs, as well as a minimization of the transfusion time.
INTRODUCTION
It is common in clinical anesthesia practice to dilute packed red blood cell (PRBC) preparations with normal saline solution prior to transfusion. This results in a decrease in viscosity which expedites the flow rate of the transfusion and consequently decreases transfusion time (de la Roche and Gauchier, 1993) .
However, the indiscriminate addition of normal saline solution to PRBCs may excessively increase the transfusion volume. This could consequently increase the transfusion time and may also lead to hemodilution as well as hypervolemia.
Therefore, an ideal amount of diluent, which would limit both transfusion time and volume, would be beneficial. This would be particularly significant in trauma patients requiring rapid as well as massive transfusions.
In addition, this optimization technique would be potentially useful for intraoperative management of blood transfusions for fluid-sensitive patients, such as those with renal failure or congestive heart failure. During surgery, when these patient populations require blood, rapid *Department of Anesthesiology, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark, New Jersey.
transfusions, without excessive hydration, would frequently be ideal.
TRANSFUSION TIME AND VOLUME
An "optimum" amount of diluent can be determined. Initially, the transfusion time can be defined as 
where P is the difference between the applied pressure to the transfusion bag and venous pressure. The radius of the tubing is r and the tubing length is 1. The viscosity of the packed red blood cells in µ.
Realizing that all the parameters in the denominator of Eq. (2) remain constant except µ, Eq. (2) can be rewritten as
Therefore, transfusion time is directly proportional to the product of transfusion volume and viscosity:
Consequently, minimizing this product would result in minimal transfusion time. The transfusion volume is simply the sum of the initial volume of the PRBC preparation, V i , and the volume of the diluent, V :
TRANSFUSION VISCOSITY
The viscosity of diluted PRBCs is an exponential function of their hematocrit (Chen et al., 1966; Eckmann et al., 2000) as shown in Fig. 1 . This relationship can be represented as (see Appendix A)
The hematocrit of the PRBCs will decrease as the volume of the diluent, V , is added. The viscosity of these diluted PRBCs will then be
where H i is the initial hematocrit of the undiluted PRBCs.
For calculation purposes, µ(H ) can be approximated using a simple exponential function which is specific for the nature of the diluent, temperature, as well as the estimated shear rate (see Appendix A and Appendix B):
In addition, this approximate viscosity can then be defined as a function of the volume of the diluent:
Therefore, the initial undiluted volume of PRBCs would have a viscosity of µ(0) = ae bH i and an initial transfusion time which would be proportional to the product of V i and µ(0).
Relative transfusion time can then be defined as
The numerator of Eq. (9) represents the final transfusion volume and final viscosity, after dilution, with a known volume V . Figure 2 illustrates how relative transfusion time decreases, then increases, as a function of added volume.
MINIMIZING ONLY TRANSFUSION TIME
By minimizing Eq. (4), a volume of diluent can be found which would result in a minimum transfusion time. Equations (8) and (5) are substituted into Eq. (4): transfusion time:
(11) Evaluating the derivative of Eq. 11 yields
The amount of added volume, where transfusion time is a minimum, can be determined by setting Eq. (12) equal to zero and solving for V :
The solution to the above is It should be noted that the relative transfusion time, for V = 571 mL, can be determined by utilizing Eq. (9):
Consequently, this much volume of diluent offers a reduction in relative transfusion time of about 66.6%.
MINIMIZING BOTH TRANSFUSION VOLUME AND TIME

The (Transfusion Time · Volume) Product
Clearly, the above solution must be modified to determine both a minimum transfusion time as well as a minimum volume of diluent. This can be accomplished by minimizing the (transfusion time · volume) product. This product is defined by modifying Eq. (10):
Note that the sum of (V i + V ) is now raised to the second power. The derivative, with respect to volume, can be determined:
Setting the right-hand side of Eq. (15) equal to zero and evaluating the derivative,
Using the same values from the prior example, H i = 75%, V i = 250, and b = 0.0438% −1 then, using Eq. (17), V = 161 mL.
The solution, which is based upon minimizing the product of transfusion time and volume, is clearly advantageous from a clinical standpoint. This is illustrated by comparing the relative transfusion times for each minimization technique as well as comparing the amount of added volume.
The relative transfusion time can be calculated, as before, using Eq. (9): Relative (transfusion time · volume) product can similarly be defined:
The benefits of this "co-minimization" technique can be assessed by comparing the values obtained from minimization of only relative transfusion time to those obtained from minimization of the relative (transfusion time · volume) product. This is illustrated in Fig. 3 .
With respect to the above examples, the reduction in the added volume of the diluent can be evaluated as 1 − 161 571 · 100% ∼ = 72%. Whereas the relative transfusion time is only marginally increased from 0.33 to 0.45. Therefore, by utilizing this combined minimization technique, an overall benefit in a reduction of transfusion time and volume is achieved. Note. Ringer's Lactate and normal saline are both similar crystalloids.
CONCLUSION
Clearly, using straightforward mathematical techniques, PRBC transfusion can be optimized with respect to both time and volume. Validation of this could readily be done using either nonhuman blood or discarded human blood. Ultimately, banked blood units might be labeled with an appropriate statement regarding dilution management.
Nonetheless, this strategy is advantageous when compared to the all-to-common indiscriminate addition of normal saline to dilute PRBC preparations. However, individual patient management demands may lead to variations in its implementation. Furthermore, fluid-sensitive patients would frequently still require the concomitant use of ancillary volume monitoring techniques. In addition, the use of arterial or venous blood gas monitoring, which is usually accompanied with hematocrit measurement, remains vital. This is particularly important during trauma, vascular, and similar procedures where blood loss can be rapid and dramatic.
APPENDIX A An Exponential Model of Red Cell Viscosity
An empirical model of red cell viscosity has been developed which shows an exponential relationship between their viscosity µ(H ) and their hematocrit H (Chen et al., 1966) : 
APPENDIX B Shear Rate
Shear rate, dv/dr, is defined as the change in velocity with respect to radius. This formula can be readily derived by first examining the radial velocity profile:
where 0 ≤ r ≤ R. dv/dr is then evaluated at r = R:
Recalling Poisuille's law:
Substituting Eq. (3A) into Eq. (2A) yields shear rate at r = R:
Substituting mean velocityV = Q/A where A = πR 2 then:
Therefore, shear rate has dimensions of s −1 . Using Eq. (6A), and an approximate flow rate of 1.3 mL/s, through a large-bore IV catheter with a radius of 0.3 cm, an estimate of the shear rate would be 4·(1.3) π ·0.3 3 = 61.3 s −1 .
